Clinical Trials Directory

Trials / Completed

CompletedNCT01823627

Pulmonary Disease in a Psychiatric Inpatient Population

Pulmonary Disease in a Psychiatric Inpatient Population, a Screening Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Psykiatrien Syd · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Purpose: Patients with mental health disorders have a reduced life expectancy, compared to the general population. The shorter life expectancy is caused by natural and unnatural death. In general, patients with a mental disorder tend to have a more unhealthy lifestyle, than the general population, characterized by e.g. lack of exercise and smoking. Hypothesis Chronic obstructive pulmonary disease (COPD) is underdiagnosed in psychiatric inpatients There is a higher prevalence of COPD in psychiatric inpatients compared to the general population Screening of patients with one respiratory symptom and a smoking history, has the same sensitivity regarding to diagnosis of COPD, as screening all patients with a smoking history Method: 80 psychiatric inpatients will undergo spirometry with reversibility test and COPD Assessment Test (CATest). Furthermore, patient history regarding respiratory symptoms and smoking will be taken into account.

Conditions

Interventions

TypeNameDescription
PROCEDURESpirometry with reversibility testSpirometry with reversibility test and CATest questionaire. following will be measured FEV1 L/s FVC L/s FEV1/FVC ration

Timeline

Start date
2013-03-01
Primary completion
2013-06-01
Completion
2013-07-01
First posted
2013-04-04
Last updated
2018-05-24

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01823627. Inclusion in this directory is not an endorsement.